RESULTS OF EVALUATING THE EFFICACY OF SECUKINUMAB VERSUS ADALIMUMAB IN TREATING PSORIATIC ARTHRITIS BY USING THE MATCHING-ADJUSTED INDIRECT COMPARISON METHOD

To date there have been no results of a direct comparison of the efficiency of using tumor necrosis factor-α inhibitors, secukinumab (SCM) and adalimumab (ADA) in particular, to treat psoriatic arthritis (PsA). This suggests that there is a need to apply the Matching-Adjusted Indirect Comparison (MA...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteur:	T. V. Korotaeva
Formaat:	Artigo
Taal:	Russo
Gepubliceerd in:	IMA-PRESS LLC 2016-12-01
Reeks:	Современная ревматология
Onderwerpen:	psoriatic arthritis clinical efficacy secukinumab adalimumab matching-adjusted indirect comparison method
Online toegang:	https://mrj.ima-press.net/mrj/article/view/720
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!